Plasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum

Malaria Journal

Volumn 4, Issue , 2005, Pages 1-13

  Sarfo, Bismark Y ^a   Armah, Henry B ^b,c   Irune, Ikovwaiza ^b   Adjei, Andrew A ^c   Olver, Christine S ^d   Singh, Shailesh ^b   Lillard Jr , James W ^b   Stiles, Jonathan K ^b  

^a University of Ghana   (Ghana)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

^d Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; MESSENGER RNA; RANTES; CCR1 PROTEIN, HUMAN; CCR1 PROTEIN, MOUSE; CCR3 PROTEIN, HUMAN; CCR3 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; IMMUNOLOGIC FACTOR; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL OCCLUSION; BRAIN DYSFUNCTION; CELL JUNCTION; CEREBELLUM; CONTROLLED STUDY; DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMATOPOIETIC CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY INFILTRATE; LEUKOCYTE; MALARIA; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PATHOGENESIS; PLASMODIUM YOELII; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTOZOAL INFECTION; RECEPTOR UPREGULATION; ULTRASTRUCTURE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CEREBELLUM; CHEMOKINE CCL5; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC FACTORS; MALARIA; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMODIUM YOELII; RECEPTORS, CCR1; RECEPTORS, CCR3; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; UP-REGULATION;

EID: 31544448833     PISSN: 14752875     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-4-63     Document Type: Article

References (39)

1. Tropical Disease Research (TDR): Malaria in: Tropical Research. In 7th Program Report UNDP/World Bank/WHO. Geneva; 1998:3-40.
2. Greenwood B: Malaria mortality and morbidity in Africa. Bull WHO 1999, 77:617-618.
3. World Health Organization (WHO): Severe Falciparum malaria. Trans R Soc Trop Med & Hyg 2000, 94(Suppl):1-90.
4. Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, Allasia C, Cataldo C, Taylor TE, Molyneux ME: Platelet accumulation in brain microvessels in fatal paediatric cerebral malaria. J Infect Dis 2003, 187:461-466.
5. Wassmer SC, Combes V, Grau GE: Pathophysiology of cerebral malaria: role of host cells in the modulation of cytoadhesion. Ann NY Acad Sci 2003, 992:30-38.
6. Wassmer SC, Coltel N, Combes V, Grau GE: Pathogenesis of cerebral malaria: facts and hypotheses. Med Trop (Mars) 2003, 63:254-257.
7. Wassmer SC, Lepolard C, Traore B, Pouvelle B, Gysin J, Grau GE: Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion activate d endothelial cells. J Infect Dis 2004, 189:180-189.
8. Sarfo BY, Singh S, Lillard JW, Quarshie A, Gyasi RK, Armah H, Adjei AA, Jolly P, Stiles JK: The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples. Ann Trop Med Parasitol 2004, 98:297-303.
9. Belnoue E, Kayabanda M, Deschemin JC: CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 2003, 101:4253-4259.
10. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Comb adiere B: Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003, 170:2221-2228.
11. Baggiolini M, Dahinden CA: C-C chemokines in allergic inflammation. Immunol Today 1994, 15:127-133.
12. Hanum PS, Hayano M, Kojima S: Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to. Plasmodium berghei 2003, 15:633-640.
13. Belnoue E, Costa FT, Vigario AM, Voza T, Gonnet F, Landau I, Van Rooijen N, Mack M, Kuziel WA, Renia L: Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 2003, 71:3648-3651.
14. Kaul DK, Nagel RL, Llena JF, Shear HL: Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. Am J Trop Med Hyg 1994, 50:512-521.
15. Shear HL, Marino MW, Wanidworanun C, Berman JW, Nagel RL: Correlation of increased expression of intercellular adhesion molecule -1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. Am J Trop Med Hyg 1998, 59:852-858.
16. Thompson WE, Powell JM, Whittaker JA, Sridaran R, Thomas KH: Immunolocalization and expression of prohibitin, a mitochondrial associated protein within the rat ovaries. Anat Rec 1999, 256:40-48.
17. Stiles JK, Molyneux DH, Wallbanks KR, Van der Vloedt AM: Effects of gamma irradiation on the midgut ultrastructure of Glossina palpalis subspecies. Radiat Res 1989, 118:353-363.
18. Grau GE, Piguet J-F, Engers HD, Louis JA, Vassalli P, Lambert P-H: L3T4+ T Lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol 1987, 237:1210-1212.
19. Neill AL, Hunt NH: Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 1992, 105:165-175.
20. Miller LH, Baruch DI, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature 2002, 415:673-679.
21. Brian SJ, de Souza JB, Riley EM: Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002, 4:291-300.
22. Tkachuk AN, Moormann AM, Poore JD, Rochford RA, Chensue SW, Mwapasa V, Meshnick SR: Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J Infect Dis 2001, 183:967-972.
23. Kameyoshi Y, Dorschner A, Mallet AI, Christopher E, Schroeder JM: Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992, 176:587-592.
24. Dessus-Babus S, Knight ST, Wyrick PB: Chlamydial infection of polarized HeLa cells induces PMN chemotaxis, but the cytokine profile varies between disseminating and non-disseminating strains. Cell Microbiol 2000, 2:317-327.
25. Rosenberger C M, Scott MG, Gold MR, Hancock RE, Finlay BB: Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol 2000, 164:5894-5904.
26. Stiles JK, Meade JC, Kucerova ZP, Thompson W, Zakeri Z, Whittaker J: Trypanosoma brucei infection induces apoptosis and upregulates neuroleukin expression in the cerebellum. Ann Trop Med Parasitol 2001, 95:797-810.
27. Keane MP, Arenberg DA, Moore BB, Addison CL, Strieter RM: CXC chemokines and angiogenesis/angiostasis. Proc Assoc Am Physi 1998, 110:288-296.
28. Lillard JW, Boyaka PN, Singh S, McGhee JR: Salmonella-mediated mucosal cell-mediated immunity. Cell Mol Biol 2001, 47:1115-1120.
29. Lillard JW, Singh UP, Boyaka PN, Singh S, Taub DD, McGhee JR: MIP1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood 2003, 101:807-814.
30. Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ: Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001, 112:174-180.
31. Sano H, Nakagawa N, Chiba R, Kurasawa K, Saito Y, Iwamoto I: Cross-linking of intercellular adhesion molecule -1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem Biophys Res Commun 1998, 29:694-698.
32. Mannheimer SB, Hariprashad J, Stoeckle MY, Murray HW: Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. Immunol Med Microbial 1996, 14:59-61.
33. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF: The cysteinecysteine family of chemokines RANTES, MIP-1α and MIP-1β induce trypanocidalactivity in human macrophages via nitric oxide. Infect Immun 1998, 66:4690-4695.
34. Sharafeldin A, Eltayeb R, Pashenkov M, Bakhiet M: Chemokines are produced in the brain early during the course of experimental African trypanosomiasis. J Neuroimmunol 2000, 103:167-170.
35. Thumwood CM, Hunt NH, Clark IA, Cowden WB: Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988, 96:579-589.
36. Pober JS, Cotran R S: Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol 1991, 50:261-302.
37. Dzenko KA, Andjelkovic AV, Kuziel WA, Packter JS: The chemokine receptor CCR2 mediates internalization of monocyte chemoattractant protein-1 along brain mic rovessels. J Neurosci 2001, 21:9214-9223.
38. Andjelkovic AV, Pachter JS: Characterization of binding sites for chemokines, MCP-1 and MIP-1a, on human brain microvessels. J Neurochem 2000, 75:1898-1906.
39. Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, Way D, Witte M, Weinand M, Said J, Kim KS, Taub D, Graves MC, Fiala M: CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med 1999, 5:795-805.